BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 35098540)

  • 1. Experience with COVID-19 convalescent plasma provides vital guidance to future pandemics.
    Hartmann J; Bloch EM; Burnouf T
    Transfusion; 2022 Mar; 62(3):681-684. PubMed ID: 35098540
    [No Abstract]   [Full Text] [Related]  

  • 2. Limitations of Safety Update on Convalescent Plasma Transfusion in COVID-19 Patients.
    Farag YMK
    Mayo Clin Proc; 2020 Dec; 95(12):2801-2802. PubMed ID: 33276848
    [No Abstract]   [Full Text] [Related]  

  • 3. In Reply - Limitations of Safety Update on Convalescent Plasma Transfusion in COVID-19 Patients.
    Joyner MJ; Senefeld JW; Klassen SA; Fairweather D; Wright RS; Carter RE
    Mayo Clin Proc; 2020 Dec; 95(12):2802-2803. PubMed ID: 33276849
    [No Abstract]   [Full Text] [Related]  

  • 4. Donating convalescent plasma for COVID-19 patients.
    Black E
    Br Dent J; 2020 Nov; 229(10):643. PubMed ID: 33247247
    [No Abstract]   [Full Text] [Related]  

  • 5. Regulatory challenges of convalescent plasma collection during the evolving stages of COVID-19 pandemic in the United States.
    Hassan S; West KA; Conry-Cantilena K; De Giorgi V
    Transfusion; 2022 Feb; 62(2):483-492. PubMed ID: 34778974
    [No Abstract]   [Full Text] [Related]  

  • 6. COVID-19 convalescent plasma: Interim recommendations from the AABB.
    Cohn CS; Estcourt L; Grossman BJ; Pagano MB; Allen ES; Bloch EM; Casadevall A; Devine DV; Dunbar NM; Foroutan F; Gniadek TJ; Goel R; Gorlin J; Joyner MJ; Metcalf RA; Raval JS; Rice TW; Shaz BH; Vassallo RR; Winters JL; Beaudoin G; Tobian AAR
    Transfusion; 2021 Apr; 61(4):1313-1323. PubMed ID: 33586160
    [No Abstract]   [Full Text] [Related]  

  • 7. COVID-19 convalescent plasma: current status, lessons from the past and future perspectives.
    Hervig TA; Flesland Ø; Nissen-Meyer LSH
    Transfus Apher Sci; 2022 Aug; 61(4):103487. PubMed ID: 35778352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New generation of vaccines and convalescent plasma therapy for management of CoV-2: Perspectives from the UK and potential deployment in the current global pandemic.
    Seghatchian J
    Transfus Apher Sci; 2021 Feb; 60(1):103051. PubMed ID: 33461918
    [No Abstract]   [Full Text] [Related]  

  • 9. [Value of convalescent plasma in the therapy of COVID-19].
    Körper S; Seifried E; Schrezenmeier H
    Dtsch Med Wochenschr; 2023 Mar; 148(7):423-426. PubMed ID: 36940693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of immunocompromised COVID-19 patients with convalescent plasma.
    Fung M; Nambiar A; Pandey S; Aldrich JM; Teraoka J; Freise C; Roberts J; Chandran S; Hays SR; Bainbridge E; DeVoe C; Roque Gardner A; Yokoe D; Henrich TJ; Babik JM; Chin-Hong P
    Transpl Infect Dis; 2021 Apr; 23(2):e13477. PubMed ID: 32989856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 convalescent plasma donor recruitment experience from the perspective of a hospital transfusion medicine service.
    Wade J; Dent EA; Wooten MS; Moosavi M; Butler H; Lough C; Verkerke H; Kamili NA; Maier CL; Josephson CD; Roback JD; Stowell SR; Sullivan HC
    Transfusion; 2021 Jul; 61(7):2213-2215. PubMed ID: 33990952
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.
    Shen C; Wang Z; Zhao F; Yang Y; Li J; Yuan J; Wang F; Li D; Yang M; Xing L; Wei J; Xiao H; Yang Y; Qu J; Qing L; Chen L; Xu Z; Peng L; Li Y; Zheng H; Chen F; Huang K; Jiang Y; Liu D; Zhang Z; Liu Y; Liu L
    JAMA; 2020 Apr; 323(16):1582-1589. PubMed ID: 32219428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 variants and convalescent plasma: reality, fallacies, and opportunities.
    Casadevall A; Henderson JP; Joyner MJ; Pirofski LA
    J Clin Invest; 2021 Apr; 131(7):. PubMed ID: 33621214
    [No Abstract]   [Full Text] [Related]  

  • 14. Successful treatment of a centenarian with coronavirus disease 2019 (COVID-19) using convalescent plasma.
    Kong Y; Cai C; Ling L; Zeng L; Wu M; Wu Y; Zhang W; Liu Z
    Transfus Apher Sci; 2020 Oct; 59(5):102820. PubMed ID: 32467007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of anti-SARS-CoV-2 hyperimmune globulin from convalescent plasma.
    Vandeberg P; Cruz M; Diez JM; Merritt WK; Santos B; Trukawinski S; Wellhouse A; Jose M; Willis T
    Transfusion; 2021 Jun; 61(6):1705-1709. PubMed ID: 33715160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First case of convalescent plasma transfusion in a child with COVID-19-associated severe aplastic anemia.
    Figlerowicz M; Mania A; Lubarski K; Lewandowska Z; Służewski W; Derwich K; Wachowiak J; Mazur-Melewska K
    Transfus Apher Sci; 2020 Oct; 59(5):102866. PubMed ID: 32636116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of Convalescent Plasma Transfusion.
    Franchini M; Glingani C
    Mayo Clin Proc; 2021 May; 96(5):1368-1369. PubMed ID: 33958067
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma from donors convalescent from SARS-CoV-2 infection-A matter of priorities.
    Farrugia A
    Transfus Clin Biol; 2020 Aug; 27(3):167-168. PubMed ID: 32563550
    [No Abstract]   [Full Text] [Related]  

  • 19. Convalescent Covid-19 plasma: Back-to-basics and ethics, and next steps.
    Garraud O; Burnouf T
    Transfus Clin Biol; 2021 Aug; 28(3):225-227. PubMed ID: 34362557
    [No Abstract]   [Full Text] [Related]  

  • 20. Convalescent plasma to treat COVID-19.
    Bloch EM
    Blood; 2020 Aug; 136(6):654-655. PubMed ID: 32761219
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.